India: Remus Pharma files Red Herring ahead of share issue

Remus Pharmaceuticals, a company is engaged in the marketing and distribution of finished formulations of pharmaceutical drugs, is set to issue 388,000 shares on the EMERGE Platform of National Stock Exchange of India. Bookrunner is Beeline Capital Advisors. Proceeds will be used to fund investments for acquisitions and general corporate purposes. Remus’ product portfolio consists…

You must be a HMI Subscriber to view this content.

Subscribe Now »